ASX - By Stock
|
PER |
Re:
per-chart
|
|
mmq1
|
491 |
112K |
7 |
02/03/24 |
02/03/24 |
ASX - By Stock
|
491
|
112K
|
7
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
mmq1
|
491 |
112K |
0 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
491
|
112K
|
0
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
mmq1
|
161 |
38K |
7 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
161
|
38K
|
7
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
mmq1
|
161 |
38K |
18 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
161
|
38K
|
18
|
|
ASX - By Stock
|
PER |
Re:
Wilsons Report - 27c 12-month target
|
|
mmq1
|
7 |
2.9K |
14 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
7
|
2.9K
|
14
|
|
ASX - By Stock
|
PER |
Re:
6 months passed since first patient
|
|
mmq1
|
161 |
38K |
7 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
161
|
38K
|
7
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
mmq1
|
3.5K |
1.0M |
9 |
29/12/23 |
29/12/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
9
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
mmq1
|
3.5K |
1.0M |
4 |
28/12/23 |
28/12/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: Annual General Meeting Presentation
|
|
mmq1
|
81 |
20K |
11 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
81
|
20K
|
11
|
|
ASX - By Stock
|
PER |
Re:
Ann: Annual General Meeting Presentation
|
|
mmq1
|
81 |
20K |
6 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
81
|
20K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Reject Name Change Resolution
|
|
mmq1
|
43 |
13K |
3 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
43
|
13K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Other indications
|
|
mmq1
|
64 |
16K |
7 |
01/08/23 |
01/08/23 |
ASX - By Stock
|
64
|
16K
|
7
|
|
ASX - By Stock
|
PER |
Re:
Ann: Trading Halt
|
|
mmq1
|
158 |
43K |
0 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
158
|
43K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Trading Halt
|
|
mmq1
|
158 |
43K |
6 |
14/07/23 |
14/07/23 |
ASX - By Stock
|
158
|
43K
|
6
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
mmq1
|
3.5K |
1.0M |
5 |
16/06/23 |
16/06/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
5
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
mmq1
|
1.0K |
298K |
15 |
09/06/23 |
09/06/23 |
ASX - By Stock
|
1.0K
|
298K
|
15
|
|
ASX - By Stock
|
PER |
Re:
Ann: Shareholder Newsletter
|
|
mmq1
|
98 |
29K |
8 |
07/06/23 |
07/06/23 |
ASX - By Stock
|
98
|
29K
|
8
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
mmq1
|
3.5K |
1.0M |
6 |
01/06/23 |
01/06/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
6
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
mmq1
|
1.0K |
298K |
6 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
1.0K
|
298K
|
6
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
mmq1
|
1.0K |
298K |
4 |
30/05/23 |
30/05/23 |
ASX - By Stock
|
1.0K
|
298K
|
4
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
mmq1
|
1.0K |
298K |
3 |
29/05/23 |
29/05/23 |
ASX - By Stock
|
1.0K
|
298K
|
3
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
mmq1
|
1.0K |
298K |
2 |
29/05/23 |
29/05/23 |
ASX - By Stock
|
1.0K
|
298K
|
2
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
mmq1
|
1.0K |
298K |
5 |
24/05/23 |
24/05/23 |
ASX - By Stock
|
1.0K
|
298K
|
5
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
mmq1
|
3.5K |
1.0M |
8 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
8
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
mmq1
|
1.0K |
298K |
4 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
1.0K
|
298K
|
4
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
mmq1
|
1.0K |
298K |
6 |
23/05/23 |
23/05/23 |
ASX - By Stock
|
1.0K
|
298K
|
6
|
|
ASX - By Stock
|
PER |
Re:
For General Information
|
|
mmq1
|
3.5K |
1.0M |
14 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
3.5K
|
1.0M
|
14
|
|
ASX - By Stock
|
PER |
Re:
Sarepta FDA Hearing
|
|
mmq1
|
99 |
28K |
10 |
16/05/23 |
16/05/23 |
ASX - By Stock
|
99
|
28K
|
10
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
mmq1
|
1.0K |
298K |
4 |
11/05/23 |
11/05/23 |
ASX - By Stock
|
1.0K
|
298K
|
4
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
mmq1
|
1.0K |
298K |
10 |
29/04/23 |
29/04/23 |
ASX - By Stock
|
1.0K
|
298K
|
10
|
|
ASX - By Stock
|
PER |
Re:
Ann: PIIb DMD trial approved in Bulgaria- UK, Australia advancing
|
|
mmq1
|
31 |
9.8K |
0 |
27/04/23 |
27/04/23 |
ASX - By Stock
|
31
|
9.8K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Albanese government pledges $50m for long Covid research as inquiry calls for action
|
|
mmq1
|
3 |
1.1K |
2 |
24/04/23 |
24/04/23 |
ASX - By Stock
|
3
|
1.1K
|
2
|
|
ASX - By Stock
|
PER |
Re:
ANP Value
|
|
mmq1
|
328 |
90K |
3 |
24/04/23 |
24/04/23 |
ASX - By Stock
|
328
|
90K
|
3
|
|
ASX - By Stock
|
PER |
Re:
ANP Value
|
|
mmq1
|
328 |
90K |
4 |
24/04/23 |
24/04/23 |
ASX - By Stock
|
328
|
90K
|
4
|
|
ASX - By Stock
|
PER |
Re:
ANP Value
|
|
mmq1
|
328 |
90K |
5 |
24/04/23 |
24/04/23 |
ASX - By Stock
|
328
|
90K
|
5
|
|
ASX - By Stock
|
PER |
Re:
ANP Value
|
|
mmq1
|
328 |
90K |
8 |
24/04/23 |
24/04/23 |
ASX - By Stock
|
328
|
90K
|
8
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
mmq1
|
1.0K |
298K |
5 |
24/04/23 |
24/04/23 |
ASX - By Stock
|
1.0K
|
298K
|
5
|
|
ASX - By Stock
|
PER |
Re:
ANP Value
|
|
mmq1
|
328 |
90K |
12 |
22/04/23 |
22/04/23 |
ASX - By Stock
|
328
|
90K
|
12
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
mmq1
|
1.0K |
298K |
6 |
21/04/23 |
21/04/23 |
ASX - By Stock
|
1.0K
|
298K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
mmq1
|
117 |
27K |
0 |
21/04/23 |
21/04/23 |
ASX - By Stock
|
117
|
27K
|
0
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
mmq1
|
1.0K |
298K |
3 |
21/04/23 |
21/04/23 |
ASX - By Stock
|
1.0K
|
298K
|
3
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
mmq1
|
1.0K |
298K |
2 |
20/04/23 |
20/04/23 |
ASX - By Stock
|
1.0K
|
298K
|
2
|
|
ASX - By Stock
|
PER |
Re:
anp chart
|
|
mmq1
|
1.0K |
298K |
3 |
20/04/23 |
20/04/23 |
ASX - By Stock
|
1.0K
|
298K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
mmq1
|
117 |
27K |
1 |
20/04/23 |
20/04/23 |
ASX - By Stock
|
117
|
27K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
mmq1
|
117 |
27K |
6 |
20/04/23 |
20/04/23 |
ASX - By Stock
|
117
|
27K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
mmq1
|
117 |
27K |
5 |
19/04/23 |
19/04/23 |
ASX - By Stock
|
117
|
27K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
mmq1
|
117 |
27K |
5 |
19/04/23 |
19/04/23 |
ASX - By Stock
|
117
|
27K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
mmq1
|
117 |
27K |
5 |
19/04/23 |
19/04/23 |
ASX - By Stock
|
117
|
27K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
mmq1
|
117 |
27K |
13 |
19/04/23 |
19/04/23 |
ASX - By Stock
|
117
|
27K
|
13
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
mmq1
|
117 |
27K |
17 |
19/04/23 |
19/04/23 |
ASX - By Stock
|
117
|
27K
|
17
|
|